Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C

The relationships betweenIFNL4genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3

(2015) J. A. Holmes et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mechanisms of liver fibrosis resolution

(2015) Frank Tacke et al.   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2015

(2015)   JOURNAL OF HEPATOLOGY

Estimates on HCV disease burden worldwide - filling the gaps

(2015) H. Wedemeyer et al.   JOURNAL OF VIRAL HEPATITIS

Association between risk factors, basal viral load, virus genotype and the degree of liver fibrosis with the response to the therapy in patients with chronic hepatitis C virus infection

(2015) Vuk Vukovic et al.   Vojnosanitetski Pregled

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis

(2015) Fabian Finkelmeier et al.   PLoS One

Update on hepatitis C virus resistance to direct-acting antiviral agents

(2014) Eva Poveda et al.   ANTIVIRAL RESEARCH

Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients

(2014) Elisabetta Degasperi et al.   ANTIVIRAL THERAPY

Vitamin D Receptor and Jak-STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN- 

(2014) C. M. Lange et al.   JOURNAL OF IMMUNOLOGY

IL28B rs 12979860 Predicts Response to Treatment in Egyptian Hepatitis C Virus Genotype 4 Patients and Alpha Fetoprotein Increases Its Predictive Strength

(2014) Samar Samir Youssef et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Common Variants in CYP2R1 and GC Genes Predict Vitamin D Concentrations in Healthy Danish Children and Adults

(2014) Janna Nissen et al.   PLoS One

Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C

(2013) Elena García-Martín et al.   PLoS One

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C

(2013) Edmondo Falleti et al.   PLoS One

Association between vitamin D and hepatitis C virus infection: A meta-analysis

(2013) Livia Melo Villar   WORLD JOURNAL OF GASTROENTEROLOGY

Sofosbuvir für Hepatitis C - Liegt die Würze in der Kürze?

(2013) H. Zimmermann et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement

(2012) Clifford J. Rosen et al.   ENDOCRINE REVIEWS

Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C

(2012) Calogero Cammà et al.   HEPATOLOGY

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

(2012) Shinya Maekawa et al.   HEPATOLOGY

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

(2012) Jose Ramón Vidal-Castiñeira et al.   JOURNAL OF HEPATOLOGY

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

(2012) Matthew T. Kitson et al.   JOURNAL OF HEPATOLOGY

Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients

(2012) Assy Nimer   WORLD JOURNAL OF GASTROENTEROLOGY

The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients

(2011) Katharina Baur et al.   ANTIVIRAL THERAPY

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

(2011) Davide Bitetto et al.   HEPATOLOGY

Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

(2011) José M Ladero et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice

(2011) Christophe Hézode   LIVER INTERNATIONAL

Vitamin D metabolism and signaling in the immune system

(2011) John H. White   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Vitamin D: Evolutionary, Physiological and Health Perspectives

(2010) Michael F. Holick   CURRENT DRUG TARGETS

Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study

(2010) Arash Miroliaee et al.   Hepatology International

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

(2010) Thomas J Wang et al.   LANCET

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin

(2010) Tarik Asselah et al.   LIVER INTERNATIONAL

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

(2009) Tania Mara Welzel et al.   HEPATOLOGY

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C

(2008) Xiaowen Su et al.   JOURNAL OF HEPATOLOGY

Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype

(2008) Hendy Abdoul et al.   PLoS One